Sign In
Buy FIXX
$0.93
+0 (+0%)
At Close: Jun 24, 2024
Catalent, Inc. (CTLT) CEO John Chiminski on Q3 2020 Results - Earnings Call Transcript
03:20pm, Saturday, 09'th May 2020
Catalent, Inc. (NYSE:CTLT) Q3 2020 Earnings Conference Call May 5, 2020 08:15 ET Company Participants Paul Surdez - Vice President, Investor Relations John Chim
The Daily Biotech Pulse: Ayala IPO, Pluristem Starts Phase 2 Trial Of COVID Treatment, European Nod For Takeda
12:00am, Friday, 08'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 7)
• Acceleron Pharma Inc (...
Homology Medicines Reports First Quarter 2020 Financial Results and Recent Highlights
08:05pm, Thursday, 07'th May 2020
- Progressed the pheNIX Trial for PKU and Added Clinical Sites, Completed Clinical Supply for Phase 1/2 and Began Manufacturing Pivotal Supply - - Executed Commercial.
May 02, 2020 (CDN Newswire via Comtex) --
A recent comprehensive study titled Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market 2020...
Homology Medicines Announces Presentations at Upcoming American Society for Gene & Cell Therapy Annual Meeting
12:00pm, Wednesday, 29'th Apr 2020
BEDFORD, Mass., April 29, 2020 -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today upcoming presentations demonstrating the broad.
American Investment Services Inc. Makes New Investment in Homology Medicines Inc (NASDAQ:FIXX)
09:12am, Wednesday, 29'th Apr 2020
American Investment Services Inc. bought a new position in shares of Homology Medicines Inc (NASDAQ:FIXX) during the 1st quarter, according to the company in its most recent Form 13F filing with the S
Analysts Offer Insights on Healthcare Companies: ObsEva SA (OBSV) and Homology Medicines (FIXX)
11:14am, Monday, 27'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ObsEva SA (OBSV) and Homology Medicines (FIXX) with bullish
Analysts Offer Insights on Healthcare Companies: ObsEva SA (NASDAQ: OBSV) and Homology Medicines (NASDAQ: FIXX)
11:13am, Monday, 27'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ObsEva SA
Biotechs Mersana Therapeutics, Crinetics See Activist Action
12:30am, Saturday, 25'th Apr 2020
Bain Capital Life Sciences plans to take an active role with Mersana, while Perceptive Advisors increased its stake in Crinetics.
Bank of New York Mellon Corp Increases Position in Homology Medicines Inc (NASDAQ:FIXX)
09:12am, Wednesday, 22'nd Apr 2020
Bank of New York Mellon Corp boosted its holdings in shares of Homology Medicines Inc (NASDAQ:FIXX) by 3.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securiti
Homology Medicines Inc (NASDAQ:FIXX) Shares Purchased by Goldman Sachs Group Inc.
10:52am, Sunday, 19'th Apr 2020
Goldman Sachs Group Inc. boosted its holdings in Homology Medicines Inc (NASDAQ:FIXX) by 35.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchan
Homology Medicines Inc (NASDAQ:FIXX) Shares Bought by Alliancebernstein L.P.
08:30am, Sunday, 19'th Apr 2020
Alliancebernstein L.P. raised its stake in shares of Homology Medicines Inc (NASDAQ:FIXX) by 7.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Co
Homology Medicines Target of Unusually Large Options Trading (NASDAQ:FIXX)
08:02am, Friday, 17'th Apr 2020
Homology Medicines Inc (NASDAQ:FIXX) was the recipient of unusually large options trading on Wednesday. Investors acquired 4,195 call options on the stock. This is an increase of 5,893% compared to th
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.86%
12:00am, Wednesday, 15'th Apr 2020
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.86%
Credit Suisse AG Sells 142,817 Shares of Homology Medicines Inc (NASDAQ:FIXX)
08:50am, Saturday, 11'th Apr 2020
Credit Suisse AG reduced its position in Homology Medicines Inc (NASDAQ:FIXX) by 93.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange
